Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced on 2/8/19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation... read more
Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, announced on 2/8/19 that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation... read more
HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched today with $60.75M in Series A funding led by ARCH Venture Partners.... read more
Vaxart has filed for an upcoming stock offering with the number of shares yet to be announced. Vaxart is developing oral vaccines based on it proprietary oral recombinant vaccine technology. The... read more
Sunstone Life Science Ventures today announced the first closing of its Sunstone Life Science Ventures Fund IV ("Sunstone LSV IV") at $91 million. The investment strategy of the new fund is a... read more
Indivior PLC (LON: INDV) (“Indivior” or the “Company”) announced on 2/2/19 that it has entered into a definitive agreement to divest its rights related to the Sai Bo Song (buprenorphine, naloxone... read more